{{Rsnum
|rsid=767199
|Gene=CYP19A1
|Chromosome=15
|position=51248190
|Orientation=plus
|GMAF=0.3517
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYP19A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 33.6 | 45.1 | 21.2
| HCB | 21.2 | 44.5 | 34.3
| JPT | 15.9 | 43.4 | 40.7
| YRI | 0.7 | 7.5 | 91.8
| ASW | 1.8 | 19.3 | 78.9
| CHB | 21.2 | 44.5 | 34.3
| CHD | 22.0 | 43.1 | 34.9
| GIH | 12.9 | 38.6 | 48.5
| LWK | 2.7 | 17.3 | 80.0
| MEX | 5.3 | 52.6 | 42.1
| MKK | 4.5 | 32.7 | 62.8
| TSI | 22.8 | 37.6 | 39.6
| HapMapRevision=28
}}

{{omim
|desc=CYTOCHROME P450, FAMILY 19, SUBFAMILY A, POLYPEPTIDE 1; CYP19A1
|id=107910
|rsnum=767199
}}

{{PMID Auto
|PMID=19064562
|Title=Genetic variation in CYP19A1 and risk of breast cancer and fibrocystic breast conditions among women in Shanghai, China.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}